Openbookopenbook
Equity
BPCR
+0.0 · +0.00%
USD · LSE

BioPharma Credit PLC(BPCR) Stock Analysis | Financial Services

USD --+0.00%
Reward42Moderate
Risk13Low
75%Data
Strong 82% profit margin · 7.2% dividend yield
Defensive Anchor
Market Cap:1.10Bn
ⓘ
Reward Rating
42
Moderate
Reward Assessment
75% data coverage
Bottom 10% of stocksView factors
ⓘ
Risk Rating
13
Low
Risk Assessment
1 metric flaggedView details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on BPCR to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
New listing — limited trading history
Fundamental and analyst data are available for BPCR, but momentum and volatility metrics will develop as more trading history accumulates (0 trading sessions so far).
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is BioPharma Credit PLC?

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets.

BPCR · Verdict

Moderate reward · low risk

BPCR stands out on volatility and cash flow, but watch the growth signal.

Based on 88% data coverage

BPCR · Verdict

What’s working & what to watch

Strengths 4

  • Volatility95/100

    Top decile vs peers

  • Cash flow89/100

    80% free-cash-flow margin

  • Balance sheet86/100

    Current ratio 4.59

  • Profitability81/100

    113% net margin · 11% ROE

Watchouts 1

  • Growth13/100

    Rev -14.7% CAGR · earnings -10.7%

Model-based scoring. For information only — not financial advice.

What is BioPharma Credit PLC?

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company is listed on the LSE in UK, operating in the Financial Services sector, with a market capitalisation of 1.10B, and a P/E ratio of 0.1x.

Financial Highlights

Investment Breakdown

Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
Profitability
Strong margins and consistent earnings support financial stability.
Risk
Below-average volatility supports a steadier risk profile.
Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (42)

The scoring profile indicates limited reward potential at this time, with profitability and valuation offering the most support. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Similar stocks to compare

A short list of Asset Management names that are close enough in size to make side-by-side comparison useful.

TFGSmall Cap / 1.1B market cap
Tetragon Financial Group Ltd
Compare
EDINSmall Cap / 1.1B market cap
Edinburgh Investment Trust
Compare
SDPSmall Cap / 1B market cap
Schroder Asia Pacific Fund
Compare
Company Information
SectorFinancial Services
IndustryAsset Management
Market Cap1.10B
P/E Ratio0.0887
Dividend Yield7.16%
Beta0.179
Insider Activity
12M windowAwaiting coverage
LSE director-dealings coverage launching later this year. The data feed is in development.
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.